Clinical Trials Browser

Phase 3 × Metastatic Castration Resistant Prostate Cancer × Abiraterone Acetate × Clear all

NCT02975934 2025-07-25

TRITON3

Phase 3 Completed

405 enrolled 34 charts 1 FDA

Metastatic Castration Resistant Prostate Cancer

NCT04056754 2019-08-14

Study of Abiraterone Acetate in Subjects With Metastatic Castration Resistant Prostate Cancer

Phase 3 Completed

Metastatic Castration Resistant Prostate Cancer